Find information on thousands of medical conditions and prescription drugs.

Exemestane

Exemestane (Trade name: Aromasin®) is an oral steroidal aromatase inhibitor used in the treatment of hormonally-responsive breast cancer.

Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Exemestant selectively targets and irreversibly binds to the aromatase enzyme, thereby inhibiting the production of estrogen.

 Home
Diseases
Medicines
A
B
C
D
E
E-Base
Ecstasy (drug)
Edecrin
Edrophonium
Edrophonium chloride
Efavirenz
Effexor
Eflornithine
Elavil
Eldepryl
Elidel
Eligard
Elitek
Elixomin
Elixophyllin
Ellagic acid
Elmiron
Eloxatin
Elspar
Emtriva
Emylcamate
Enalapril
Enalaprilat
Enalaprilat
Endep
Enflurane
Enoxaparin sodium
Entacapone
Enulose
Epi-pen
Epinephrine
Epirubicin
Epitol
Epivir
Epogen
Eprosartan
Ergocalciferol
Ergoloid Mesylates
Ergotamine
Eryc
Eryped
Erythromycin
Esgic
Eskalith
Esmolol
Estazolam
Estazolam
Estrace
Estraderm
Estradiol
Estradiol
Estradiol valerate
Estring
Estrogel
Estrone
Estrostep
Ethacridine
Ethambutol
Ethchlorvynol
Ethosuximide
Ethotoin
Etiracetam
Etodolac
Etopophos
Etoposide
Etorphine
Evista
Exelon
Exemestane
Hexal Australia
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org
• [List your site here Free!]

Aromasin approved as adjuvant
From OB/GYN News, 12/1/05

Aromasin (exemestane tablets) is approved as an adjuvant treatment for post-menopausal women with estrogen receptor-positive breast cancer who have received 2-3 years of tamoxifen and are switched to Aromasin for completion of a total of 5 consecutive years of adjuvant hormonal therapy. For more information, contact Pfizer Inc. by visiting www.pfizeroncology.com/products/aromasin.aspx or by calling 800-438-1985.

COPYRIGHT 2005 International Medical News Group
COPYRIGHT 2006 Gale Group

Return to Exemestane
Home Contact Resources Exchange Links ebay